HealthSource Integrative Medical Centre is proud to share that we are one of eleven clinics taking part in The Canadian/US Integrative Oncology Study (CUSIOS) to explore the impact of advanced integrative care delivered by Naturopathic Doctors for patients with advanced cancer. This is an optional study for any patients that wish to be a part of it.
Integrative oncology aims to combine the best of conventional and whole-person naturopathic care seamlessly and safely to: improve survival, enhance quality of life, reduce side effects from conventional treatments and help prevent recurrence. The goals of the Canadian/US Integrative Oncology Study (CUSIOS) are to observe and measure the overall survival of late stage cancer patients who receive advanced integrative oncology treatments, and to describe integrative therapies provided by naturopathic doctors.
A total of 400 people with advanced breast, colorectal, pancreatic, and ovarian cancer will be studied in one of eleven clinics across North America over three years. Each participating advanced integrative oncology clinic provides comprehensive whole-person care in naturopathic oncology, applying advanced science-based treatment for people with late-stage cancer.
How does someone become part of the study?
Dr Reid at HealthSource Integrative Medical Centre will screen each and every oncology patient to determine whether or not they are eligible candidates for the study. This occurs during the initial assessment as a new patient. If a patient both meets the eligibility criteria and accepts the opportunity to participate, they will be guided through an informed consent process and entered into the study.
What does it mean for the patient?
The design of this study is observational, meaning that the recommendations and care a patient receives is no different whether a patient is in the study or not. The results are reviewed in retrospect, after they have occurred, and are not changed or modified during the course of the study. The study is focused on the collection of information only, in order to advance the field of advanced integrative oncology.